Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia

Pediatric Dermatology

Volumn 21, Issue 6, 2004, Pages 633-635

  Zargari, Omid ^a   Kimyai Asadi, Arash ^b,c   Jafroodi, Maryam ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ADULT; ARTICLE; CAFE AU LAIT SPOT; CHILD; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; DRUG EFFECT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; HYPERPIGMENTATION; LEG ULCER; MALE; MEDICAL EXAMINATION; MYELOPROLIFERATIVE DISORDER; NAIL DISEASE; PRIORITY JOURNAL; PSORIASIS; SICKLE CELL ANEMIA; SKIN TOXICITY; THALASSEMIA MINOR; XEROSIS;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROXYUREA; HYPERPIGMENTATION; INFANT; MALE; NAIL DISEASES; SKIN; THALASSEMIA; TIME FACTORS;

EID: 10644277061     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0736-8046.2004.21603.x     Document Type: Article

References (17)

1. Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L. Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 1999;62:221-227.
2. Rund D, Rachmilewitz E. New trends in the treatment of beta-thalassemia. Crit Rev Oncol Hematol 2000;33:105-118.
3. Boyd AS, Neldner KH. Hydroxyurea therapy. J Am Acad Dermatol 1991;25:518-524.
4. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975;111:183-187.
5. Best PJ, Daoud MS, Pittelkow MR, Petitt RM. Hydroxyurea-induced leg ulceration in 14 patients. Ann Intern Med 1998;128:29-32.
6. Bahadoran P, Castanet J, Lacour JPH, et al. Pseudodermatomyositis induced by long-term hydroxyurea therapy: report of two cases. Br J Dermatol 1996;134:1161-1162.
7. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol 1997;36:178-182.
8. Eming SA, Peters T, Hartmann K, Scharffetter-Kochanek K, Mahrle G. Lichenoid chronic graft-versus-host disease-like acrodermatitis induced by hydroxyurea. J Am Acad Dermatol 2001;45:321-322.
9. O'Branski EE, Ware RE, Prose NS, Kinney TR. Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy. J Am Acad Dermatol 2001;44:859-861.
10. Chaine B, Neonato MG, Girot R, Aractingi S. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. Arch Dermatol 2001;137:467-470.
11. Najean Y, Rain JD. Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65 years. Blood 1997;90:3370-3377.
12. Baran R, Kechijian P. Longitudinal melanonychia (melanonychia striata): diagnosis and management. J Am Acad Dermatol 1989;21:1165-1175.
13. Vomvouras S, Pakula AS, Shaw JM. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol 1991;24:1016-1017.
14. Nixon DW. Alteration in nail pigment after cancer chemotherapy. Arch Intern Med 1976;136:1117-1118.
15. de Montalembert M, Belloy M, Bernaudin F, et al. Three-year follow-up of hydroxyurea treatment in several ill children with sickle cell disease. J Pediatr Hematol Oncol 1997;19:13-18.
16. Aste N, Fumo G, Contu F, Aste N, Biggio P. Nail pigmentation caused by hydroxyurea: report of 9 cases. J Am Acad Dermatol 2002;47:146-147.
17. Fekri A, Shamsaddini S, Maghsoodloonejad A. Skin and mucous membrane lesions in major B-thalassemia. Iran J Dermatol 2000;12:7-17.